HBB: A Drug Target / Disease Biomarker (G3043)

Target Name: HBB

NCBI ID: G3043

Content of Review Report on HBB Target / Biomarker

HBB

HBB: A Drug Target / Disease Biomarker

HBB (Hemoglobinopathy B) is a group of rare genetic disorders that affect the structure and function of hemoglobin, which is a protein in red blood cells that carries oxygen from the lungs to the rest of the body. These disorders can cause a wide range of symptoms, including anemia, fatigue, and weakness, and can also lead to complications such as infections and organ damage.

HBB is a drug target (or biomarker) because it can be used to treat certain types of HBB disorders. For example, a drug called K oximetacillin is currently being tested for the treatment of HBB disorders. This drug works by inhibiting the production of a protein that is involved in the formation of the invalid hemoglobin molecule. By doing this, it can help to improve the delivery of oxygen to the body's cells.

Another drug that is being studied for the treatment of HBB disorders is called SML-3029. This drug works by inhibiting the production of a protein that is involved in the formation of the invalid hemoglobin molecule. It is also being tested for the treatment of other types of HBB disorders.

In addition to being used as a drug, HBB is also being used as a biomarker to diagnose and monitor certain types of HBB disorders. For example, a blood test that measures the level of a protein called HBB-alpha is often used to diagnose HBB disorders. This protein is produced by the body and is found in the blood. The level of HBB-alpha in the blood can be affected by a variety of factors, including the severity of anemia, which can be a symptom of HBB disorders.

Overall, HBB is a drug target (or biomarker) that has the potential to treat and diagnose certain types of HBB disorders. Further research is needed to fully understand the effects of these drugs and to develop more effective treatments for this group of disorders.

Protein Name: Hemoglobin Subunit Beta

Functions: Involved in oxygen transport from the lung to the various peripheral tissues

The "HBB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HBB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets